RCM Technologies Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $333.6M+19.8% YoYTTM through 4 Jul 2026
Net Income $17.1M+28.4% YoYTTM through 4 Jul 2026
Free Cash Flow $22.8MTTM through 4 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 27.5% |
| EBITDA Margin | 8.4% |
| Operating Margin | 7.9% |
| Net Margin | 5.1% |
Returns
35.5%ROE
12.2%ROA
25.6%ROIC
Balance Sheet Health
Debt / Equity0.54x
Current Ratio1.85x
Net Debt$21.8M
Cash & Equivalents$6.6M
Quality Metrics
Altman Z-Score5.80
Piotroski F-Score7 / 9
FCF Margin6.8%
Rule of 408.3
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2026: $319.4M
Diluted EPS$2.30TTMFY2026: $2.14
Dividend
$1.00Per share, FY20170.00%Yield
Capital Allocation
Capex Intensity0.3%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Specialty Health Care | $164.1M | +15.0% | |
| Engineering | $120.5M | +24.9% | |
| Life Sciences, Data and Solutions | $34.8M | -11.3% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.